{"altmetric_id":20543206,"counts":{"readers":{"mendeley":62,"citeulike":0,"connotea":1},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["nice"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4ee3cf058f610002c44","authors":["von Minckwitz, Gunter","K\u00fcmmel, Sherko","Vogel, Petra","Hanusch, Claus","Eidtmann, Holger","Hilfrich, J\u00f6rn","Gerber, Bernd","Huober, Jens","Costa, Serban Dan","Jackisch, Christian","Loibl, Sibylle","Mehta, Keyur"],"doi":"10.1093\/jnci\/djn089","first_seen_on":"2017-05-26T09:39:25+00:00","issns":["0027-8874","1460-2105"],"issue":"8","journal":"JNCI: Journal of the National Cancer Institute","last_mentioned_on":1463702400,"links":["http:\/\/dx.doi.org\/10.1093\/jnci\/djn089"],"pdf_url":"https:\/\/academic.oup.com\/jnci\/article-pdf\/100\/8\/552\/7683998\/djn089.pdf","pmid":"18398094","pubdate":"2008-04-16T00:00:00+00:00","publisher":"Oxford University Press","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study","type":"article","volume":"100","mendeley_url":"http:\/\/www.mendeley.com\/research\/intensified-neoadjuvant-chemotherapy-earlyresponding-breast-cancer-phase-iii-randomized-gepartrio-st"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":7772166,"mean":6.6362066801147,"rank":1901898,"this_scored_higher_than_pct":62,"this_scored_higher_than":4823564,"rank_type":"exact","sample_size":7772166,"percentile":62},"similar_age_3m":{"total_number_of_other_articles":99534,"mean":11.119531190661,"rank":29306,"this_scored_higher_than_pct":69,"this_scored_higher_than":69324,"rank_type":"exact","sample_size":99534,"percentile":69},"this_journal":{"total_number_of_other_articles":4308,"mean":12.430301834223,"rank":1862,"this_scored_higher_than_pct":38,"this_scored_higher_than":1658,"rank_type":"exact","sample_size":4308,"percentile":38},"similar_age_this_journal_3m":{"total_number_of_other_articles":34,"mean":43.994545454545,"rank":16,"this_scored_higher_than_pct":50,"this_scored_higher_than":17,"rank_type":"exact","sample_size":34,"percentile":50}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":7,"Researcher":17,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":13,"Student  > Postgraduate":2,"Other":5,"Student  > Master":5,"Student  > Bachelor":1,"Lecturer":1,"Lecturer > Senior Lecturer":2,"Professor":5},"by_discipline":{"Engineering":1,"Medicine and Dentistry":46,"Economics, Econometrics and Finance":1,"Agricultural and Biological Sciences":2,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":3,"Unspecified":8}}},"geo":{"mendeley":{"US":3,"JP":2,"SD":1,"DK":1,"GB":2,"RU":1}}},"posts":{"policy":[{"title":"Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer: Committee papers","url":"https:\/\/www.nice.org.uk\/guidance\/TA424\/documents\/committee-papers-2","license":"public","citation_ids":[2796993,441443,5388592,6003907,15777390,220149,484422,16032151,2432476,20543191,20543196,20543201,20543206,20543213,20543218,20543227,20543230,20543235,20328340,20543244,20543254,20543260,6079779,20543272,3714360,1395822,1965931,20543282,393158,1508999,20543295,6424001,228135,16032153,20543314,16223469,228134,2796993,20543322,17917837,2432348,15418035,4048115,20543341,20543348,20543359,1465466,16676877,1096677,2606863,15063707,662920,3820787,596604,1631861,2198613,482929,3247880,20543422,786661,20543441,6096408,1145378,2604858,4663308,9908035,2120553,3968682,159346,483980,1809776,2873579,17926024,6235475,20543531,4684905,20543554,393158,2796993,4684905,4684905,20543601,4684905],"posted_on":"2016-05-20T00:00:00+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/ta424\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-c538532fd05eafb8bcf6a2c191ad82fa133a1b27a3b8c378ef4dfa0be44bcfa4.jpg"}}]}}